Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Aileron Therapeutics, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
1.60%
EBIT to Interest (avg)
-24.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0
Tax Ratio
2.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
37.28%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.89
EV to EBIT
-1.39
EV to EBITDA
-1.39
EV to Capital Employed
0.87
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-62.46%
ROE (Latest)
-48.66%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Movement
4What is working for the Company
NET PROFIT(HY)
Higher at USD -12.32 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
-2What is not working for the Company
CASH AND EQV(HY)
Lowest at USD 13.15 MM
DEBT-EQUITY RATIO
(HY)
Highest at -11.92 %
Here's what is working for Aileron Therapeutics, Inc.
Net Profit
Higher at USD -12.32 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Aileron Therapeutics, Inc.
Cash and Eqv
Lowest at USD 13.15 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -11.92 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






